112 related articles for article (PubMed ID: 11549428)
1. Modelling the future costs of breast screening.
Johnston K
Eur J Cancer; 2001 Sep; 37(14):1752-8. PubMed ID: 11549428
[TBL] [Abstract][Full Text] [Related]
2. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
Butler JR; Furnival CM; Hart RF
Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
4. Will early detection of breast cancer reduce the costs of treatment?
Salkeld G; Gerard K
Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
6. [The cost of screening for breast and cervical cancer in France].
Watt S
Bull Cancer; 2003 Nov; 90(11):997-1004. PubMed ID: 14706904
[TBL] [Abstract][Full Text] [Related]
7. Screening for breast cancer: time, travel, and out-of-pocket expenses.
Secker-Walker RH; Vacek PM; Hooper GJ; Plante DA; Detsky AS
J Natl Cancer Inst; 1999 Apr; 91(8):702-8. PubMed ID: 10218508
[TBL] [Abstract][Full Text] [Related]
8. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
9. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
[TBL] [Abstract][Full Text] [Related]
10. The patient burden of screening mammography recall.
Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a proposed breast cancer screening regimen.
Knox EG
BMJ; 1988 Sep; 297(6649):650-4. PubMed ID: 3179545
[TBL] [Abstract][Full Text] [Related]
12. The costs of treating breast cancer in the United Kingdom: implications for screening.
Wolstenholme JL; Smith SJ; Whynes DK
Int J Technol Assess Health Care; 1998; 14(2):277-89. PubMed ID: 9611903
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
14. Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021.
Hunter DJ; Drake SM; Shortt SE; Dorland JL; Tran N
Cancer Detect Prev; 2004; 28(6):453-60. PubMed ID: 15582269
[TBL] [Abstract][Full Text] [Related]
15. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
Giorgi R; Reynaud J; Wait S; Seradour B
Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
[TBL] [Abstract][Full Text] [Related]
16. Effect of subject age on costs of screening for colorectal cancer.
Whynes DK; Walker AR; Hardcastle JD
J Epidemiol Community Health; 1992 Dec; 46(6):577-81. PubMed ID: 1494071
[TBL] [Abstract][Full Text] [Related]
17. Current and future costs of cancer.
Koopmanschap MA; van Roijen L; Bonneux L; Barendregt JJ
Eur J Cancer; 1994; 30A(1):60-5. PubMed ID: 8142167
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
